Working Groups: Creating Meaningful Change, Together
In 2021, we established four unique working groups to address key areas of interest in the advocacy community – identified via direct advocate feedback – focused on:
- Health Equity: Racial & Ethnic Health and Healthcare Disparities
- Health Equity: Access to Care
- Patient Voice/Patient-Focused Drug Development (PFDD)
- The Future of Advocacy
Our Working Groups meet throughout the year to progress actions that will address needs and opportunities in these focus areas. We welcome you to learn more about each group below, check out content from previous meetings, and participate in one or more of these Working Groups to use your voice, lead and learn.
Working Group Descriptions
Sheila Thorne
President and CEO, Multicultural Healthcare Marketing Group, LLC
Health Equity:
Racial & Ethnic Health and
Healthcare Disparities
Many social and economic factors drive health outcomes. However, there are associated structural, institutional and systemic disparities that need to be corrected for everyone to have...
More Info >
Brad Love (Emcee)
Ph.D., Co-Founder and Chief Culture Officer, GRYT Health
Health Equity:
Access to Care
Advancements in medicine and technology are creating better outcomes than ever, which makes the disparities in accessing care even more devastating...
More Info >
Neil Bertelsen
HTAi Patient and Citizen Involvement Group
Patient Voice/Patient-Focused
Drug Development
Patient involvement is increasingly being recognized as important to successful research and development of medicines and care. Patient-focused drug development...
More Info >
Gary Nolan
Chief Executive Officer, Colab Health
The Future
of Advocacy
The role of patient advocacy organizations is changing. There are increased demands, new challenges, and also emerging opportunities for creating meaningful...
More Info >